All posts

Antifreeze: Why don’t Antarctic fish freeze to death?

Fish living in the oceans around Antarctica seem like they should freeze to death. But notothenioids have it all figured out, thanks to the antifreeze proteins in their blood

It sounds like the superpower possessed by a lower level Marvel Comics superhero.

And while having antifreeze in your blood might be useful in those cases where one might say, be fighting crime in Moscow in December or uncovering crimes related to ice-cream trafficking, it’s an absolutely vital adaptation for fish living in the frigid waters of the Antarctic, where the water temperatures average minus 1.9 Celsius.

A video series called Reactions, produced by The American Chemical Society and PBS Digital Studios tackles the question of why fish in this area are not fish-cicles (Video below).

These special fish, called notothenioids, are a group that has evolved to sport a defense best described as a “biochemical antifreeze”. The fish have antifreeze proteins in their bodies that attach to the surface of ice crystals. These antifreeze glycoproteins, or AFGPs, are a more powerful defense against extreme cold than a Canada Goose parka fighting the cold winds on Toronto’s Front Street.

“This antifeeze action is so powerful it effectively creates a gap in the freezing point of the fish’s body fluid between where they should freeze and where they actually do,” says Alexa Billow, who wrote and narrated the video. They lower the fish’s internal freezing point by more than a degree Celsius, to as low as -2.7. Since the sea water can’t get much colder than it’s freezing point of -1.9, the fish literally can’t freeze.

This antifreeze super power is not exactly unique to the creatures of the Antarctic. Fish such as herring and scuplin and even insects such as certain beetles have the antifreeze adaptation, to varying degrees.

Billow notes that the type of antifreeze proteins are being explored for consumer applications such as preventing large ice crystals from forming on frozen ice cream and for improving the transport of live organs. Presumably, an array of applications lies between these oddly paired examples.

So does this clever adaptation mean notothenioids will be chilling out millions of years after mankind is gone? Maybe not, says a study published in the Journal of Experimental Biology by Jody M. Beers and Nishad Jayasundara, which concluded that warming conditions in the area may turn the feat into a mere parlour trick

“How notothenioids will fare in the rapidly changing Southern Ocean remains an open question,” the authors says. “It is interesting to speculate what will become of the biochemical adaptations to low, near-freezing temperatures, such as the AFGPs, which may no longer be needed in a warmer ocean. Indeed, production and maintenance of these proteins are likely to be energetically costly and may be selected against over time. Reduction and loss of AFGPs has already been documented in notothenioids that have migrated to warmer latitudes from endemic waters with seemingly no negative repercussions.

Below: How Not to Freeze a Fish

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

7 hours ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

8 hours ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

9 hours ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

1 day ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

1 day ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

1 day ago